The Clinical Usefulness of Prostate Specific Antigen: Update 1994
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
In conclusion, PSA is the first prostate specific serum marker of clinical usefulness in urology. It represents a valuable clinical tool that has improved our ability to detect early prostate cancer and to monitor response to therapy. While large PSA screening studies have demonstrated an appreciable increase in the detection of organ confined, potentially curable prostate cancers, no study to date has yet demonstrated that the increased detection rate will decrease the prostate cancer-specific mortality rate. Yet more importantly, no study to date has demonstrated that early diagnosis using PSA will not decrease the prostate cancer specific mortality rate and until such data exist, PSA should be used to aid in early diagnosis and treatment planning for men with prostate cancer. PSA, when combined with other variables such as Gleason score and clinical stage, improves the prediction of pathological stage for prostate cancer. The introduction of PSA velocity and age specific reference ranges should further enhance the clinical usefulness of PSA. New advances in PSA research hold great promise for further improvements in PSA, and truly make it the most important and useful tumor marker for adenocarcinoma of the prostate.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate
Stamey, T. A., Yang, N., Hay, A. R., McNeal, J. E., Freiha, F. S., & Redwine, E. (1987) · New England Journal of Medicine · doi:10.1056/nejm198710083171501 · Cited by 2,451
Measurement of Prostate-Specific Antigen in Serum as a Screening Test for Prostate Cancer
Catalona, W. J., Smith, D. S., Ratliff, T. L., Dodds, K. M., Coplen, D. E., Yuan, J. J. J., Petros, J. A., & Andriole, G. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199104253241702 · Cited by 2,361
Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35410-1 · Cited by 1,278
Self-citationOesterling, J. E. (1993) · JAMA · doi:10.1001/jama.270.7.860 · Cited by 1,266
Self-citationOesterling, J. E. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)38491-4 · Cited by 1,230
Self-citationLongitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480160073037 · Cited by 1,096
Stenman, U., Leinonen, J., Alfthan, H. V., Rannikko, S., Tuhkanen, K., & ALFTHAN, O. S. (1991) · PubMed · Cited by 1,072
Catalona, W. J. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510080052031 · Cited by 998
Boring, C. C., Squires, T. S., & Tong, T. (1993) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.43.1.7 · Cited by 966
Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin
Lilja, H., Christensson, A., Dahlén, U., Matikainen, M. T., Nilsson, O., Pettersson, K., & Lövgren, T. (1991) · Clinical Chemistry · doi:10.1093/clinchem/37.9.1618 · Cited by 910
Purification of a Human Prostate Specific Antigen
Wang, M. C., Valenzuela, L. A., Murphy, G. P., & Chu, T. M. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.100 · Cited by 825
Oesterling, J. E. (1993) · JAMA · doi:10.1001/jama.1993.03510070082041 · Cited by 807
Self-citationCooner, W. H., Mosley, B. R., Rutherford, C. L., Beard, J. H., Pond, H. S., Terry, W. J., Igel, T. C., & Kidd, D. D. (1990) · Journal of Urology · doi:10.1016/s0022-5347(17)40211-4 · Cited by 767
Benson, M. C., Whang, I. S., Pantuck, A. J., Ring, K. S., Kaplan, S. A., Olsson, C. A., & Cooner, W. H. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)37393-7 · Cited by 763
Oesterling, J. E., Chan, D. W., Epstein, J. I., Kimball, A. W., Bruzek, D. J., Rock, R. C., Brendler, C. B., & Walsh, P. C. (1988) · The Journal of Urology · doi:10.1016/s0022-5347(17)42630-9 · Cited by 573
Self-citationGutman, A. B., & Gutman, E. B. (1938) · Journal of Clinical Investigation · doi:10.1172/jci100974 · Cited by 553
PURIFICATION OF A HUMAN PROSTATE SPECIFIC ANTIGEN
WANG, M. C., VALENZUELA, L. A., MURPHY, G. P., & CHU, T. M. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)65270-6 · Cited by 550
Clinical use of Prostate Specific Antigen in Patients with Prostate Cancer
Hudson, M. A., Bahnson, R. R., & Catalona, W. J. (1989) · Journal of Urology · doi:10.1016/s0022-5347(17)38972-3 · Cited by 491
SERUM PSA AFTER ANATOMIC RADICAL PROSTATECTOMY
Partin, A. W., Pound, C. R., Clemens, J. Q., Epstein, J. I., & Walsh, P. C. (1993) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00924-1 · Cited by 460
Self-citationSerum Prostate Specific Antigen as Pre-Screening Test for Prostate Cancer
Labrie, F., Dupont, A., Suburu, R., Cusan, L., Tremblay, M., Gomez, J.-L., & Emond, J. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37402-5 · Cited by 337
Kabalin, J. N., Hodge, K. K., McNeal, J. E., Freiha, F. S., & Stamey, T. A. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)38746-3 · Cited by 258
Carter, H. B., Morrell, C. H., Pearson, J. D., et al. (1992) · PubMed · Cited by 240
Richie, J. P., Catalona, W. J., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., Dekernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., et al. (1993) · Urology · doi:10.1016/0090-4295(93)90359-i · Cited by 230
Stamey, T. A., Kabalin, J. N., & Ferrari, M. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)41176-1 · Cited by 224
Frazier, H. A., Robertson, J. E., Humphrey, P. A., et al. (1993) · The Journal of Urology · doi:10.1016/s0022-5347(17)36132-3 · Cited by 217
Stamey, T. A., Kabalin, J. N., Ferrari, M., & Yang, N. (1989) · Journal of Urology · doi:10.1016/s0022-5347(17)41177-3 · Cited by 205
Use of human prostate-specific antigen in monitoring prostate cancer.
Kuriyama, M., Wang, M. C., Lee, C., Papsidero, L. D., Killian, C. S., Inaji, H., Slack, N. H., Nishiura, T., Murphy, G. P., & Chu, T. M. (1981) · PubMed · Cited by 192
Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: Followup
Kaplan, I. D., Cox, R. S., & Bagshaw, M. A. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)36133-5 · Cited by 174
Chan, D. W., Bruzek, D. J., Oesterling, J. E., Rock, R. C., & Walsh, P. C. (1987) · Clinical Chemistry · doi:10.1093/clinchem/33.10.1916 · Cited by 171
Self-citationMiller, J. I., Ahmann, F. R., Drach, G. W., Emerson, S. S., & Bottaccini, M. R. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37432-3 · Cited by 163
Iwakiri, J., Grandbois, K., Wehner, N., Graves, H. C. B., & Stamey, T. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)36207-9 · Cited by 146
Hara, M., Koyanagi, Y., Inoue, T., & Fukuyama, T. (1971) · PubMed · Cited by 145
Prognostic Significance of Prostate Specific Antigen in Endocrine Treatment for Prostatic Cancer
Arai, Y., Yoshiki, T., & Yoshida, O. (1990) · The Journal of Urology · doi:10.1016/s0022-5347(17)39757-4 · Cited by 122
Yu, H., & Diamandis, E. P. (1993) · Clinical Chemistry · doi:10.1093/clinchem/39.10.2108 · Cited by 120
The Effect of Digital Rectal Examination on Prostate-Specific Antigen Levels
Crawford, E. D. (1992) · JAMA · doi:10.1001/jama.1992.03480160085039 · Cited by 100
Prostatic intraepithelial neoplasia: A premalignant lesion
Brawer, M. K. (1992) · Human Pathology · doi:10.1016/0046-8177(92)90104-b · Cited by 97
Prostate Specific Antigen: Not Detectable Despite Tumor Progression after Radical Prostatectomy
Goldrath, D. E., & Messing, E. M. (1989) · The Journal of Urology · doi:10.1016/s0022-5347(17)38998-x · Cited by 73
False Positive Prostate Specific Antigen Values in the Sera of Women with Renal Cell Carcinoma
Pummer, K., Wirnsberger, G. H., Pürstner, P., Stettner, H. M., & Wandschneider, G. (1992) · The Journal of Urology · doi:10.1016/s0022-5347(17)36497-2 · Cited by 47
PSA leads the way for detecting and following prostate cancer.
Oesterling, J. E. (1993) · PubMed · Cited by 12
Self-citationp53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Design of the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial
Prorok, P. C., Andriole, G. L., Bresalier, R. S., Buys, S. S., Chia, D., David Crawford, E., Fogel, R., Gelmann, E. P., Gilbert, F., Hasson, M. A., et al. (2000) · Controlled Clinical Trials · doi:10.1016/s0197-2456(00)00098-2 · Cited by 1,037
Imaging Prostate Cancer: A Multidisciplinary Perspective
Hricak, H., Choyke, P. L., Eberhardt, S. C., Leibel, S. A., & Scardino, P. T. (2007) · Radiology · doi:10.1148/radiol.2431030580 · Cited by 601
PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING
POLASCIK, T. J., OESTERLING, J. E., & PARTIN, A. W. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68543-6 · Cited by 599
Self-citationProstate Specific Antigen Best Practice Statement: 2009 Update
Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, A. O., Stanford, J. L., Zietman, A., et al. (2009) · Journal of Urology · doi:10.1016/j.juro.2009.07.093 · Cited by 517
P504S: A New Molecular Marker for the Detection of Prostate Carcinoma
Jiang, Z., Woda, B. A., Rock, K. L., Xu, Y., Savas, L., Khan, A., Pihan, G., Cai, F., Babcook, J. S., Rathanaswami, P., et al. (2001) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200111000-00007 · Cited by 365
Metadata
- Authors
- Partin, A. W., & Oesterling, J. E.
- Venue
- Journal of Urology
- Published
- 1994-11
- Volume
- 152
- Issue
- 5 Part 1
- Pages
- 1358-1368
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W127182478
- Cited by
- 390
- References
- 40
- FWCI
- 42.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.